Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-0463481 succinate is a potent and orally active dual antagonist of CCR2/CCR5 with comparable human and rodent CCR2 potency with IC50 of 20.8 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | PF-0463481 succinate is a potent and orally active dual antagonist of CCR2/CCR5 with comparable human and rodent CCR2 potency with IC50 of 20.8 nM. |
Targets&IC50 | COX-2:20.8 nM, COX-5:470 nM |
In vivo | Early intervention with PF-04634817 induces an additional increase in glycated hemoglobin (HbA1c) levels[1]. |
Molecular Weight | 629.67 |
Formula | C29H42F3N5O7 |
CAS No. | 2140301-98-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-04634817 succinate 2140301-98-8 Immunology/Inflammation Neuroscience COX PF04634817 Succinate PF 04634817 Succinate PF 04634817 succinate PF-04634817 Succinate PF04634817 succinate inhibitor inhibit